Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib
about
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Assessment of Resistance Mecha ...... ired Resistance to Osimertinib
@en
type
label
Assessment of Resistance Mecha ...... ired Resistance to Osimertinib
@en
prefLabel
Assessment of Resistance Mecha ...... ired Resistance to Osimertinib
@en
P2093
P1433
P1476
Assessment of Resistance Mecha ...... ired Resistance to Osimertinib
@en
P2093
Amanda J Redig
Cloud P Paweletz
Daniel B Costa
David J Kwiatkowski
Geoffrey R Oxnard
Hatim Husain
Kathryn F Mileham
Kenneth S Thress
Lynette M Sholl
Michael S Rabin
P304
P356
10.1001/JAMAONCOL.2018.2969
P50
P577
2018-11-01T00:00:00Z